Flange Pharmaceuticals Private Limited, a active private limited company, was established on 29 January 2016 in Noida, Uttar Pradesh, India. Engaging in dentalcare within the hospital and medical care sector, it holds CIN: U24233UP2016PTC076137. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Vijay Bahadur Singh (Director), Neeta Singh (Director), Rashmi Singh (Director). Past directors included Avinash Singh, Anup Kumar. It holds ₹0.98 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No- Gh01, Sec-4, 4Th Avenue Gaur City, Block-D, Greater Noida, Noida, Uttar Pradesh, 201301.
U24233UP2016PTC076137
076137
29 January 2016
₹0.50 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Flange Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Bahadur Singh | Director | 29 Jan 2016 | Current |
| Neeta Singh | Director | 02 Mar 2021 | Current |
| Rashmi Singh | Director | 02 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jun 2021 | Past |
| Pramod Abcsdd | Director | 15 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Flange Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Flange Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹980,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Apr 2022 | Others | ₹0.98 M | Open |
Explore comprehensive loan charge details -
Flange Pharmaceuticals has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Flange Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flange Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Flange Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Flange Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Progress on A charge with Others amounted to Rs. 0.98 M with Charge ID 100560190 was registered on 11 Apr 2022. was documented.
Neeta Singh was appointed as a Director was appointed as a Director on 02 Mar 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
Rashmi Singh was appointed as a Director was appointed as a Director on 02 Mar 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
Progress on Vijay Bahadur Singh was appointed as a Director was appointed as a Director on 29 Jan 2016 & has been associated with this company since 9 years 10 months . was documented.
The CIN of Flange Pharmaceuticals Private Limited is U24233UP2016PTC076137.
Flange Pharmaceuticals Private Limited is headquartered at Plot No- Gh01, Sec-4, 4Th Avenue Gaur City, Block-D, Greater Noida, Noida, Uttar Pradesh, 201301.
Flange Pharmaceuticals Private Limited was incorporated on 29 January 2016.
The current directors of Flange Pharmaceuticals Private Limited are
The primary industry of Flange Pharmaceuticals Private Limited is Hospital And Medical Care.
Flange Pharmaceuticals Private Limited is unlisted.
The authorized capital of Flange Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Flange Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX